background
emerg
depart
ed
challeng
influenza
season
patient
present
acut
sporad
ed
visit
ed
manag
larg
empir
often
occur
without
reliabl
diagnost
need
target
therapi
safe
outpati
discharg
hospit
admiss
object
evalu
impact
influenza
diagnosi
physician
decis
make
ed
visit
use
coba
liat
influenza
b
assay
studi
design
prospect
studi
assess
impact
rapid
min
reversetranscriptas
polymeras
chain
reaction
rtpcr
influenza
test
physician
decis
make
ed
physician
respons
establish
preand
postdiagnosi
manag
cours
requir
confirm
via
secondari
document
medic
record
chang
physician
decis
make
analyz
across
four
clinic
touchpoint
admissiondischarg
statu
ii
medic
procedur
iii
antivir
antibiot
prescrib
iv
laboratori
studi
result
influenza
diagnosi
chang
patient
manag
cours
rel
empir
prediagnosi
plan
case
result
cost
save
patient
day
influenza
season
result
cost
save
visit
evalu
ed
patient
visit
project
cost
save
due
defer
admiss
reduct
antivir
prescrib
sensit
edbas
influenza
test
use
coba
liat
assay
equival
central
lab
test
sensit
specif
respect
conclus
provid
rapid
rtpcr
influenza
test
ed
set
action
use
guid
patient
care
decis
understand
cascad
event
link
influenza
diagnosi
ed
provid
overal
cost
save
offset
cost
provid
edbas
test
larg
empir
occur
without
access
diagnost
test
support
target
therapi
safe
outpati
discharg
hospit
admiss
patient
ill
requir
care
gener
hospit
bed
icu
molecular
influenza
test
ed
patient
area
activ
investig
mani
group
compar
new
molecular
platform
tradit
test
method
demonstr
increas
sensit
improv
antivir
util
newer
pcr
assay
technolog
contribut
overal
reduct
length
inpati
stay
time
isol
howev
access
rtpcr
still
unabl
reach
nearli
patient
time
direct
admiss
decis
ed
test
occur
central
laboratori
thu
key
question
surround
clinic
util
financi
impact
rapid
molecular
test
ed
patient
still
exist
studi
attempt
examin
rapid
molecular
test
within
context
ed
visit
patient
histori
physic
h
p
exam
studi
examin
clinic
impact
molecular
test
among
ed
patient
limit
analysi
analyt
sensit
specif
comparison
addit
studi
target
test
util
focu
antivir
prescrib
alon
overlook
cascad
manag
decis
accompani
influenza
diagnosi
without
studi
design
assess
valu
edbas
test
within
time
frame
patient
encount
remain
difficult
assess
whether
rtpcr
test
perform
ed
provid
addit
valu
compar
test
perform
central
hospit
laboratori
typic
ed
visit
central
concept
establish
clinic
util
assumpt
test
result
use
direct
patient
manag
ed
visit
time
influenc
physician
decis
make
systemat
analysi
assumpt
lack
address
unansw
question
employ
novel
prospect
studi
design
evalu
day
influenza
season
primari
aim
evalu
impact
new
rapid
rtpcr
assay
roch
coba
liat
liat
assay
physician
decis
make
ed
patient
visit
chang
physician
decis
make
post
influenza
diagnosi
analyz
across
four
clinic
touchpoint
secondari
aim
target
costeffect
rtpcr
test
ed
determin
base
hospit
charg
physician
document
intern
classif
diseas
code
icd
nation
ed
benchmark
data
may
studi
period
cdc
adjust
vaccin
efficaci
influenza
reduc
protect
influenza
virus
season
occur
circul
influenza
virus
analyz
cdc
experienc
antigen
drift
comparison
virus
cover
vaccin
patient
present
ed
studi
period
least
one
sign
compat
influenza
infect
includ
fever
cough
sore
throat
muscl
ach
elig
enrol
investig
group
compris
ed
physician
medic
resid
student
volunt
laboratori
staff
assembl
examin
impact
rapid
influenza
test
clinic
decis
make
emerg
depart
clade
studi
approv
hcmc
ethic
institut
review
board
chang
physician
decis
make
repres
depend
variabl
patient
manag
plan
prior
influenza
diagnosi
prior
test
serv
control
variabl
assess
impact
rapid
rtpcr
test
ed
twostag
prospect
studi
design
defin
preand
postdiagnosi
manag
cours
captur
rel
impact
influenza
diagnosi
fig
stage
defin
empir
manag
cours
ed
patient
present
least
one
symptom
compat
influenza
studi
survey
administ
ed
physician
prior
influenza
test
part
ed
h
p
exam
defin
baselin
ed
manag
cours
studi
survey
compris
questionnair
span
four
clinic
touchpoint
admissiondischarg
statu
ii
medic
procedur
iii
antivir
antibiot
prescrib
iv
laboratori
studi
ed
physician
document
clinic
likelihood
influenza
base
evalu
present
patient
symptom
clinic
likelihood
influenza
assess
base
physician
assess
high
moder
low
likelihood
influenza
minim
subject
often
associ
survey
respons
requir
secondari
document
respons
relat
medic
order
procedur
lab
medic
state
survey
match
document
order
report
electron
medic
record
emr
time
studi
liat
assay
yet
receiv
clinic
laboratori
improv
amend
clia
waiver
waiv
test
could
run
nonlaboratori
personnel
outsid
laboratori
hospit
util
satellit
laboratori
locat
ed
staf
laboratori
personnel
perform
influenza
test
liat
assay
ed
upon
receipt
influenza
rtpcr
test
result
secondari
studi
survey
survey
distribut
ed
physician
involv
initi
h
p
exam
captur
impact
influenza
diagnosi
rtpcr
test
result
patient
manag
cours
survey
respons
also
requir
ed
physician
document
chang
medic
manag
emr
traceabl
survey
respons
emr
requir
total
uniqu
influenza
sampl
symptomat
patient
collect
via
nasopharyng
flock
swab
ml
univers
viral
transport
media
utm
becton
dickinson
spark
md
usa
sampl
test
liat
influenza
ab
assay
detect
presenc
influenza
influenza
b
viral
rna
test
perform
per
product
insert
avail
assay
briefli
nasopharyng
sampl
collect
univers
transport
media
transfer
use
transfer
pipett
uncap
liat
cartridg
contain
pcr
consum
includ
extract
sampl
fill
preset
volum
establish
liat
cartridg
cartridg
reseal
place
liat
instrument
sensit
specif
liat
test
compar
genmark
esensor
rvp
assay
carlsbad
california
usa
current
goldstandard
test
result
use
hospit
perform
central
laboratori
genmark
test
perform
accord
manufactur
instruct
rna
extract
perform
use
fdaclear
applic
biomerieux
easymag
marcyietoil
franc
confirm
posit
neg
liat
result
confirm
correspond
posit
neg
result
genmark
esensor
case
test
result
liat
genmark
esensor
assay
differ
third
molecular
assay
biofir
rp
assay
salt
lake
citi
utah
usa
use
sampl
serv
resolv
conflict
liat
genmark
esensor
result
biofir
rp
test
perform
per
manufactur
instruct
recognit
respiratori
virus
patient
present
influenza
symptom
area
recent
investig
made
possibl
introduct
number
fda
clear
respiratori
panelbas
assay
genmark
esensor
assay
use
compar
test
studi
detect
addit
respiratori
virus
influenza
thu
abl
report
distribut
respiratori
virus
seen
case
review
fig
valu
repres
percentag
case
respiratori
viru
detect
rsv
respiratori
syncyti
viru
hmpv
human
metapneumonviru
piv
parainfluenza
influenza
b
viru
detect
case
addit
respiratori
viru
codetect
virus
singl
case
three
respiratori
virus
detect
codetect
virus
data
repres
n
patient
meet
inclus
criteria
total
number
case
one
viru
detect
total
dark
bar
repres
case
involv
hospit
admiss
ed
light
bar
depict
case
discharg
ed
case
examin
requir
admiss
hospit
influenza
viru
detect
case
respiratori
viru
influenza
account
remain
hospit
admiss
case
coronaviru
adenoviru
piv
detect
admit
patient
often
difficult
defin
consequ
test
result
patient
manag
medic
condit
impact
care
limit
evalu
patient
main
diagnosi
code
pneumonia
influenza
acut
respiratori
infect
chronic
obstruct
pulmonari
diseas
alli
condit
patient
respiratori
ill
code
primari
medic
condit
patient
present
multipl
complex
code
exclud
evalu
impact
rapid
influenza
diagnosi
could
clearli
captur
compar
patient
present
isol
defin
respiratori
ill
physician
survey
respons
requir
verif
requir
ed
document
survey
respons
manag
plan
emr
case
survey
respons
primari
studi
survey
prediagnosi
could
trace
correspond
medic
order
medic
note
exclud
consult
ed
staff
expect
influenza
result
min
establish
threshold
expect
turnaround
time
need
guid
physician
decis
make
within
typic
ed
visit
case
met
associ
inclus
criteria
use
evalu
felt
import
assess
turnaround
time
achiev
liat
assay
ed
total
total
case
test
liat
assay
case
survey
respons
secondari
studi
survey
postdiagnosi
could
trace
correspond
medic
order
medic
note
exclud
addit
verifi
accuraci
physician
respons
secondari
document
need
order
assess
cost
associ
medic
manag
result
influenza
diagnosi
us
medic
code
hospit
bill
depend
physician
document
therefor
chang
medic
manag
state
physician
requir
traceabl
emr
defin
icd
code
requir
hecon
analysi
failur
compet
either
phase
survey
n
phase
survey
n
inabl
verifi
physician
responsesact
emr
n
exclud
fig
hecon
model
develop
describ
impact
rapid
rtpcr
influenza
test
ed
manag
suspect
influenza
patient
examin
four
clinic
touchpoint
admiss
discharg
statu
ii
medic
procedur
iii
antiviralantibiot
prescrib
iv
laboratori
studi
fig
cost
associ
laboratori
studi
antiinfect
therapi
medic
procedur
taken
directli
hospit
bill
cost
associ
admiss
ed
hospit
diagnosi
pneumonia
respiratori
infect
without
complex
code
taken
preestablish
benchmark
standard
determin
nation
inpati
sampl
databas
includ
nationwid
emerg
depart
sampl
healthcar
cost
util
project
statist
analysi
perform
use
binomi
one
sampl
test
null
hypothesi
proport
result
total
uniqu
patient
sampl
inclus
adult
pediatr
case
test
ed
use
liat
assay
larger
patient
set
use
defin
analyt
test
perform
liat
assay
tabl
well
defin
practic
provid
min
turnaround
time
ed
use
largest
patient
data
set
avail
us
patient
test
n
present
symptom
compat
cdc
ili
case
definit
select
patient
randomli
distribut
februari
may
although
patient
sampl
test
liat
assay
total
n
case
met
associ
inclus
criteria
requir
evalu
healthcar
econom
analysi
hecon
fig
n
patient
present
least
one
symptom
fever
cough
sore
throat
muscl
ach
consist
influenza
median
patient
age
year
rang
week
year
patient
met
cdc
criteria
ili
defin
temperatur
least
cough
sore
throat
without
anoth
obviou
caus
consid
high
risk
influenza
infect
accord
establish
risk
factor
influenzaposit
rate
n
sensit
specif
liat
ci
ci
respect
tabl
result
liat
genmark
assay
differ
n
case
adjust
data
resolv
case
favor
origin
liat
influenza
result
adjust
sensit
base
addit
third
resolv
assay
biofir
rp
report
ci
ci
tabl
ili
case
definit
report
sensit
ci
specif
ci
respect
tabl
clinic
diagnosi
determin
ed
physician
assess
report
sensit
specif
ci
ci
respect
presenc
fever
carri
sensit
specif
ci
ci
respect
among
influenza
neg
case
respiratori
viru
influenza
influenza
b
detect
case
two
virus
individu
patient
detect
case
influenza
posit
case
case
examin
requir
admiss
hospit
influenza
viru
detect
case
respiratori
viru
influenza
account
remain
hospit
admiss
case
coronaviru
adenoviru
parainfluenza
virus
detect
admit
patient
respect
influenza
detect
case
evalu
howev
chang
patient
manag
result
rapid
influenza
test
ed
involv
p
tabl
chang
patient
manag
assess
rel
empir
manag
cours
establish
prior
influenza
test
chang
patient
manag
cours
time
like
occur
among
influenza
neg
case
compar
influenza
posit
case
highlight
import
sensit
test
assur
high
neg
predict
valu
administr
discontinu
antivir
antimicrobi
result
influenza
diagnosi
commonli
document
chang
manag
occur
n
p
case
result
decreas
inappropri
unsupport
antibiot
antivir
prescrib
respect
inappropri
antibiot
prescrib
defin
use
antibiot
confirm
influenza
infect
convers
inappropri
antivir
oseltamivir
prescrib
defin
use
antivir
set
neg
influenza
diagnosi
neg
influenza
result
increas
laboratori
test
addit
medic
procedur
n
n
case
respect
chang
admiss
discharg
statu
occur
case
account
document
chang
patient
manag
total
patient
avoid
initi
plan
hospit
admiss
provid
rapid
influenza
result
convers
patient
initi
hospit
admiss
plan
subsequ
admit
posit
influenza
test
result
whilst
debat
turnaround
time
need
provid
pcr
test
influenza
ed
exist
littl
debat
regard
intent
edbas
pcr
test
order
test
provid
tangibl
benefit
result
action
key
object
test
produc
result
quicker
could
routin
offer
contemporari
central
test
within
context
discret
patient
visit
consult
ed
staff
defin
turnaround
time
liat
test
min
among
total
case
test
receiv
influenza
result
ed
within
min
order
entri
case
rapid
result
min
could
achiev
among
case
min
turnaround
time
could
achiev
averag
turnaround
time
rang
howev
among
case
involv
patient
encount
ed
stabil
room
requir
higher
level
care
within
ed
patient
often
longer
complic
ed
manag
thu
understand
mani
patient
seen
ed
stabil
room
would
experi
delay
laboratori
test
test
becom
less
prioriti
compar
resuscit
patient
occur
ed
stabil
room
addit
factor
contribut
turnaround
time
min
could
determin
remain
case
defer
cost
associ
antivir
prescrib
result
net
cost
save
day
uniqu
patient
encount
increas
antibiot
util
net
cost
associ
combin
antiviralantibiot
prescrib
account
net
save
equat
overal
cost
save
visit
chang
patient
manag
determin
four
cirtitc
touchpoint
includ
chang
rel
initi
prediagnosi
manag
h
p
exam
admssiondischarg
order
antibioticsantivir
perscrib
medic
procedru
ultrasound
chest
xray
lumbar
punctur
electrocardiogram
computer
tomographi
scan
laboratori
studi
troponin
sputum
cultur
blood
cultur
procalicitonin
respiratori
viral
panel
pcr
ddimer
urin
cultur
urin
analysi
cbc
creactiv
protein
bmp
tuberculosi
igra
legionella
urinari
antigen
liver
enzym
test
total
initi
hospit
admiss
order
antimicrobi
prescript
medic
procedur
laboratori
test
impact
respons
rapid
influenza
test
result
actual
cost
associ
chang
manag
reflect
incur
defer
cost
tabl
optim
patient
manag
reli
recognit
appropri
clinic
symptom
knowledg
healthcar
provid
avail
reliabl
diagnost
strong
predict
valu
capabl
allow
manag
decis
made
confid
demonstr
access
rapid
min
sensit
rtpcr
test
influenza
impact
patient
manag
case
demonstr
rapid
influenza
result
ed
action
use
ed
physician
help
guid
patient
manag
valu
proposit
examin
rapid
rtpcr
test
demonstr
reduct
unnecessari
antibiot
prescript
decreas
time
diagnosi
reduc
length
stay
within
ed
roger
colleagu
recent
compar
rapid
multiplex
pcr
test
tradit
batch
pcr
test
among
pediatr
ed
patient
demonstr
associ
rapid
diagnosi
antibiot
stewardship
reduc
length
stay
decreas
time
diagnosi
howev
despit
statist
signific
respect
time
diagnosi
test
unavail
pediatr
ed
patient
time
influenc
ed
admiss
studi
defin
clinic
valu
rapid
rtpcrbase
influenza
howev
fall
short
establish
clinic
util
ed
test
test
occur
central
laboratori
locat
ed
visit
studi
one
first
attempt
examin
role
provid
diagnosi
ed
visit
within
ed
use
rapid
point
care
molecular
test
experi
demonstr
provid
diagnosi
nearer
patient
present
continu
action
event
impact
medic
manag
case
greatest
impact
empir
medic
manag
affect
antimicrobi
stewardship
process
highlight
relationship
rapid
diagnost
appropri
antibiot
antivir
prescrib
previous
describ
develop
small
molecul
monoclon
therapi
influenza
infect
grow
import
access
rapid
sensit
diagnost
capabl
guid
antivir
prescrib
treatment
decis
becom
import
find
support
experi
requir
diagnost
support
suspect
influenza
case
particularli
relev
given
recent
experi
demonstr
clinic
recognit
influenza
present
ed
patient
lack
sensit
experi
confirm
previou
investig
found
clinic
sensit
influenza
among
ed
patient
ancillari
test
order
includ
laboratori
test
medic
procedur
increas
post
influenza
diagnosi
find
contrast
previou
studi
conclud
rapid
test
control
ancillari
test
differ
explain
part
examin
wider
rang
laboratori
medic
procedur
compar
studi
addit
studi
demonstr
base
total
number
ed
patient
meet
inclus
criteria
n
confid
interv
ili
case
definit
use
cdc
defin
ili
cdc
fever
least
least
cough
sore
throat
without
known
caus
influenza
physician
assess
influenza
determin
directli
queri
likelihood
influenza
present
ed
patient
base
present
symptom
alon
made
prior
influenza
test
clinic
likelihood
influenza
record
direct
respons
ed
physician
base
assess
high
moder
low
likelihood
influenza
reduct
test
order
frequent
focu
posit
influenza
result
given
bia
highli
like
vast
major
influenza
test
often
neg
result
greater
util
laboratori
test
test
expand
support
narrow
differenti
diagnos
cost
save
associ
rapid
rtpcr
test
ed
visit
base
larg
deferr
hand
patient
influenza
diagnosi
allow
safe
discharg
ed
expand
data
edpati
visit
report
cost
save
demonstr
diagnost
support
import
factor
support
effici
patient
care
help
limit
healthcar
cost
conclud
find
underestim
overal
clinic
impact
influenza
test
observ
studi
studi
design
mani
influenza
seri
reli
preand
posttest
cohort
subject
differ
patient
acuiti
season
influenza
strain
differ
among
physician
behavior
collect
influenc
data
set
patient
test
influenza
flu
season
often
present
addit
comorbid
patient
manag
decis
length
hospit
stay
influenc
medic
issu
independ
influenza
statu
account
vast
major
preand
postintervent
studi
order
determin
impact
influenza
diagnosi
patient
manag
felt
import
minim
confound
variabl
independ
affect
physician
manag
decis
approach
allow
us
target
impact
influenza
test
also
exclud
number
patient
influenza
diagnosi
import
addit
n
patient
min
test
result
could
achiev
spent
time
ed
stabil
room
acuiti
patient
requir
stabil
ed
high
patient
undoubtedli
addit
medic
condit
respiratori
infect
also
benefit
rapid
access
influenza
diagnosi
thu
limit
evalu
patient
influenza
test
could
stringent
analyz
acknowledg
patient
influenza
diagnosi
would
help
exclud
part
studi
design
limit
patient
enrol
defin
respiratori
infect
allow
us
target
effect
diagnosi
studi
group
demonstr
posit
clinic
financi
impact
rapid
influenza
diagnosi
like
underestim
valu
provid
rapid
edbas
rtpcr
test
cost
infrastructur
need
support
edbas
test
fall
outsid
scope
current
studi
aim
defin
util
influenza
diagnosi
ed
howev
recent
experi
liat
assay
use
variou
ed
clinic
locat
indic
test
reliabl
perform
nonlaboratori
staff
nurs
physician
alliedhealth
profession
note
studi
test
occur
ed
environ
perform
laboratori
staff
acknowledg
util
test
use
nonlaboratori
personnel
ed
primari
aim
studi
provid
influenza
test
within
ed
deliv
result
within
time
frame
typic
ed
visit
describ
impact
diagnosi
patient
manag
util
gain
use
nonlaboratori
personnel
perform
test
requir
first
demonstr
provid
test
clinic
benefit
infrastructur
need
support
pointof
care
test
complex
requir
staf
support
laboratori
oversight
avail
physician
space
educ
often
poorli
defin
mani
studi
address
studi
mani
variabl
place
prior
studi
impact
cost
associ
test
although
acknowledg
cost
associ
edbas
test
may
differ
other
find
demonstr
provid
rtpcr
test
ed
patient
visit
action
result
influenc
chang
physician
decis
make
case
costeffect
approach
conclus
lend
support
addit
studi
systemat
describ
oper
insight
need
pointof
care
test
report
describ
epidemiolog
respiratori
virus
influenza
among
ed
patient
clinic
concern
virus
influenza
continu
evolv
lend
support
comprehens
panelbas
approach
respiratori
viru
test
whether
syndromicrespiratori
viru
test
perform
ed
visit
time
influenc
manag
current
debat
mani
panelbas
respiratori
test
often
reserv
hospit
acut
ill
patient
util
comprehens
respiratori
viru
test
establish
among
ed
popul
find
support
influenza
infect
primari
viru
detect
present
patient
primari
viru
associ
major
hospit
patient
ed
potenti
limit
studi
lack
circul
influenza
viru
time
evalu
case
posit
influenza
viru
recent
studi
indic
liat
assay
highli
sensit
influenza
b
virus
lack
influenza
present
time
studi
realiti
epidemiolog
season
influenza
infect
howev
clinic
experi
demonstr
influenza
b
caus
similar
ill
present
overlap
clinic
present
typic
respond
similarli
oseltamivir
therapi
effort
captur
impact
influenza
diagnosi
ed
inclus
influenza
infect
thu
interpret
find
context
influenza
despit
rel
low
number
influenza
infect
encount
time
studi
benefit
diagnost
test
deriv
identifi
treat
true
posit
weigh
harm
fail
detect
influenza
symptomat
patient
event
pandem
outbreak
earli
treatment
associ
decreas
mortal
compar
treatment
odd
ratio
confid
interv
emphas
import
diagnost
support
time
antivir
respons
us
healthcar
struggl
rise
cost
wast
healthcar
expenditur
diagnost
test
increasingli
view
import
compon
patient
manag
influenc
hospit
cost
expand
diagnost
test
nontradit
test
locat
ed
area
activ
interest
costbenefit
analys
requir
conclud
appli
rapid
accur
rtpcr
test
influenza
ed
influenc
patient
manag
case
studi
result
cost
save
visit
provid
rapid
rtpcr
test
ed
set
warrant
consider
partial
fund
studi
provid
unrestrict
educ
grant
roch
molecular
gth
minneapoli
medic
research
grant
thank
dr
sara
love
provid
critic
comment
thank
faculti
staff
depart
emerg
medicin
hennepin
counti
medic
center
